28 August 2012

Boehringer-Ingelheim Vetmedica Inc to invest $79 million and create 115 new jobs in Missouri

St. Joseph, Mo. – 28 August 2012 - Boehringer-Ingelheim Vetmedica Inc., a global leader in the animal health industry, is making a $79 million investment in Missouri as it builds a new warehouse and administration building at its St. Joseph campus, Gov. Jay Nixon announced today. Altogether, this investment and new facilities are expected to create 115 new jobs over the next three years

"Boehringer-Ingelheim Vetmedica Inc. is an anchor of the Animal Health Corridor, and this latest expansion in St. Joseph strengthens our state's standing as a leader in this worldwide industry," Gov. Nixon said. "Here in Missouri, we've balanced our budget every year, held the line on taxes and invested in our schools and workforce. This stable and positive business climate has moved our economy in the right direction and attracted global companies, such as this one, to make new investments and create new jobs here in Missouri." 

Boehringer Ingelheim Vetmedica Inc. is a subsidiary of the global Boehringer Ingelheim Corporation which has been headquartered in St. Joseph since 1981. The company is a worldwide leader in biological research, development, and manufacturing for the animal health business, with the St. Joseph location dedicated to the production, distribution and administrative operation for animal vaccines. 

The corporation is constructing the new 260,000 square-foot consolidated packaging and physical distribution warehouse to consolidate all warehousing, packaging and labeling functions under one roof to make increase efficiency in getting products to its customers. Combined with the new administration building, which was also officially dedicated today, the corporation's current expansion will create 115 new jobs with a capital investment of $79 million. 

To assist Boehringer-Ingelheim Vetmedica in moving forward with its growth plans, the company could be eligible for a strategic economic incentive package from the state of Missouri if it meets the strict job creation and investment criteria of each program. 

"Missouri's pro-business climate of low and predictable taxes, a trained and ready workforce and commitment to growing our economy has made our state the best place in the Midwest for companies to invest, expand and prosper," Gov. Nixon said. "We are committed to helping companies create jobs and moving our economy in the right direction." 

CNN-Money recently rated Missouri as the nation's sixth-best state for new business start-ups in its '10 Most Entrepreneurial States for 2011', with Missouri being the only Midwestern state in the Top 10. In addition, Missouri's state exports were up six percent during the first two quarters of 2012 compared to 2011, a year when the state of Missouri set a record with $14.1 billion in export sales revenue. 

Boehringer Ingelheim Vetmedica, Inc. (BIVI), is the U.S. animal health division of Boehringer Ingelheim Corporation, a family-owned company founded in 1885 in Ingelheim, Germany. Boehringer Ingelheim Corporation is an international corporation of 18 operative subsidiaries and four representative offices as well as local distributors in more than 50 countries around the globe. With its own research, production and distribution facilities, the Boehringer Ingelheim Corporation ranks among the top 20 pharmaceutical companies worldwide. 

Source: Office of Missouri Governor and Boehringer Ingelheim Vetmedica